Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes

doi:10.1084/jem.155.1.231

This Article

	Full Text (PDF, 1127K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Pfaffenbach, G.
	Articles by Gigli, I.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Pfaffenbach, G.
	Articles by Gigli, I.


Social Bookmarking

	What's this?

ARTICLES

Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes

G Pfaffenbach, ME Lamm and I Gigli

Activation of the complement system by IgA was investigated with immune complexes containing a mouse IgA myeloma protein with specificity for phosphorylcholine linked to bovine serum albumin (PC-BSA). These IgA anti-PC-BSA immune complexes activated the alternative complement pathway in mouse and guinea pig serum, while human complement was not affected. The activation proceeded with consumption of C3 but little or no consumption of C5. C3 did not bind to the IgA immune complexes during complement activation although it did bind covalently to IgG immune complexes. It is suggested that IgA immune complexes do not supply a suitable surface for C3 binding and effective alternative pathway convertase assembly; therefore, cleavage is limited and occurs primarily in the fluid phase. Without C3 binding, C5 cleavage does not occur nor can the alternative pathway activation proceed to the amplification step.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Taube, C., Thurman, J. M., Takeda, K., Joetham, A., Miyahara, N., Carroll, M. C., Dakhama, A., Giclas, P. C., Holers, V. M., Gelfand, E. W. (2006). Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc. Natl. Acad. Sci. USA 103: 8084-8089 [Abstract] [Full Text]
Pilette, C., Durham, S. R., Vaerman, J.-P., Sibille, Y. (2004). Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?. Proc Am Thorac Soc 1: 125-135 [Abstract] [Full Text]
Pilette, C., Ouadrhiri, Y., Godding, V., Vaerman, J-P., Sibille, Y. (2001). Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 18: 571-588 [Abstract] [Full Text]
Brandt, E. R., Hayman, W. A., Currie, B., Carapetis, J., Jackson, D. C., Do, K.-A., Good, M. F. (1999). Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Int Immunol 11: 569-576 [Abstract] [Full Text]
Marcotte, H., Lavoie, M. C. (1998). Oral Microbial Ecology and the Role of Salivary Immunoglobulin A. Microbiol. Mol. Biol. Rev. 62: 71-109 [Abstract] [Full Text]
CONLEY, M. E., DELACROIX, D. L. (1987). Intravascular and Mucosal Immunoglobulin A: Two Separate but Related Systems of Immune Defense?. ANN INTERN MED 106: 892-899 [Abstract]